• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by AKAMPION

< Previous 1 2 3 Next >
News headline image
tiakis Biotech Successfully Completes Data Package to Advance Tiprelestat into Phase II clinical trial in PAH
December 02, 2025
From AKAMPION
Via GlobeNewswire
News headline image
Captain T Cell Closes Financing Round to Advance its Proprietary, Next-Generation TCR-T Pipeline Into the Clinic
November 17, 2025
From AKAMPION
Via GlobeNewswire
News headline image
selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease
October 21, 2025
From AKAMPION
Via GlobeNewswire
News headline image
ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors
October 20, 2025
From AKAMPION
Via GlobeNewswire
News headline image
Omnix Medical Secures $25 Million in Series C Funding Co-Led by Harel Insurance & Finance and the EIC Fund
October 15, 2025
From AKAMPION
Via GlobeNewswire
News headline image
Stanford University Secures NIH Grant to Advance tiakis Biotech´s Elafin (Tiprelestat) Through a U.S. Phase II Trial in Pulmonary Arterial Hypertension
September 08, 2025
From AKAMPION
Via GlobeNewswire
News headline image
BellaSeno Establishes High-Profile Clinical Advisory Board
August 18, 2025
From AKAMPION
Via GlobeNewswire
News headline image
Mabylon AG Raises CHF 30 Million to Advance Peanut Allergy Lead Program MY006 to Clinical Proof-of-Concept
August 12, 2025
From AKAMPION
Via GlobeNewswire
News headline image
MetrioPharm’s MP1032 Receives EMA Orphan Drug Designation in Duchenne Muscular Dystrophy
July 29, 2025
From AKAMPION
Via GlobeNewswire
News headline image
Ebenbuild Secures Euro 2.3 Million EIC Grant to Scale Digital Twin Platform for Respiratory Health
July 02, 2025
From AKAMPION
Via GlobeNewswire
News headline image
Thermosome Reports Encouraging Clinical Data of THE001 in Advanced Soft Tissue Sarcomas
June 24, 2025
From AKAMPION
Via GlobeNewswire
News headline image
Captain T Cell Joins Bayer Co.Lab Berlin to Accelerate Autologous and Allogeneic TCR-T Cell Therapy Programs for Cancer Patients
June 17, 2025
From AKAMPION
Via GlobeNewswire
News headline image
tiakis Biotech AG Announces Appointment of ex-Actelion Executive Christoph Schmidt as New Supervisory Board Member
May 21, 2025
From AKAMPION
Via GlobeNewswire
News headline image
Thermosome Receives U.S. Orphan Drug Designation for Lead Compound THE001, Expands Patent Estate
May 12, 2025
From AKAMPION
Via GlobeNewswire
News headline image
Dr. Stephan Rietiker elected as new Chairman of the Board of MetrioPharm AG
April 23, 2025
From AKAMPION
Via GlobeNewswire
News headline image
1STBIO and LigaChemBio Announce Strategic R&D and Licensing Option Agreement
April 22, 2025
From AKAMPION
Via GlobeNewswire
News headline image
Four new members elected to the Board of Directors of MetrioPharm AG
April 17, 2025
From AKAMPION
Via GlobeNewswire
News headline image
1ST Biotherapeutics Joins The Michael J. Fox Foundation’s LITE Program to Advance LRRK2-Based Parkinson’s Disease Research
April 15, 2025
From AKAMPION
Via GlobeNewswire
News headline image
Ebenbuild Contributes Cutting-Edge Digital Lung Simulations to Pulmonary Fibrosis Drug Development
April 09, 2025
From AKAMPION
Via GlobeNewswire
News headline image
New Clinical Data on BellaSeno’s Novel, Resorbable Breast Implants Presented at The Aesthetic MEET 2025
March 24, 2025
From AKAMPION
Via GlobeNewswire
News headline image
AMYRA Publishes Landmark Review Supporting New Gluten Digestion Approach for Celiac Disease
February 25, 2025
From AKAMPION
Via GlobeNewswire
News headline image
BellaSeno Successfully Completes Two Clinical Trials with Novel, Resorbable Breast Implants
January 14, 2025
From AKAMPION
Via GlobeNewswire
News headline image
tiakis Biotech AG Receives Positive Scientific Advice from the U.S. FDA for Planned Phase II Trial of Tiprelestat
January 08, 2025
From AKAMPION
Via GlobeNewswire
News headline image
Next-generation RNA company Inverna Therapeutics launched by Argobio and University of Southern Denmark
January 07, 2025
From AKAMPION
Via GlobeNewswire
News headline image
tiakis Biotech AG Reports Clinical Phase Ib/II Trial Results of Tiprelestat for the Treatment of Hospitalized COVID-19 Patients
December 09, 2024
From AKAMPION
Via GlobeNewswire
News headline image
Thermosome Initiates Final Dose Level in Phase I Trial of Lead Compound THE001
December 04, 2024
From AKAMPION
Via GlobeNewswire
News headline image
Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001
November 19, 2024
From AKAMPION
Via GlobeNewswire
News headline image
Ebenbuild Appoints Charles A. Taylor, PhD as Chairman of the Board
November 11, 2024
From AKAMPION
Via GlobeNewswire
News headline image
AMYRA Successfully Demonstrates a New Therapeutic Paradigm for Gluten-Related Disorders in a First-in-Human Study
October 23, 2024
From AKAMPION
Via GlobeNewswire
News headline image
Preliminary Data of BellaSeno’s Clinical Trial on Scaffold-Guided Breast Regeneration Presented at the 93rd Annual Plastic Surgery Meeting in San Diego, CA
October 09, 2024
From AKAMPION
Via GlobeNewswire
< Previous 1 2 3 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap